PRESS RELEASE
News
-
-
PRESS RELEASE
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
OSE Immunotherapeutics acknowledges FDA Orphan Drug Designation granted to pegrizeprument (VEL-101) for organ rejection prevention in liver transplant patients. Veloxis Pharmaceuticals to develop and commercialize the product globally -
-
-
-
REGULATED PRESS RELEASE
Eiffage wins in consortium the contract to replace the steel bridge over the Kiel Canal in Germany
Eiffage, in consortium with BEMO Tunnelling and Metrostav DIZ, wins €183 million contract to replace the historic Levensau Bridge over the Kiel Canal in Germany, enhancing regional transportation network -
-
-
PRESS RELEASE
Paul Chan attends the World Economic Forum Annual Meeting in Switzerland; spotlights Hong Kong’s advantages as an international hub for trade and finance
Hong Kong Financial Secretary Paul Chan participates in the 56th Annual Meeting of the World Economic Forum in Davos, discussing Hong Kong's digital asset development and global collaborations -
